Authors: HAHKAKEMPPINEN M MUHONEN T NORDLING S PYRHONEN S

Citation: M. Hahkakemppinen et al., DNA FLOW-CYTOMETRY AND THE OUTCOME OF CHEMOIMMUNOTHERAPY IN METASTATIC MELANOMA, Melanoma research, 7(4), 1997, pp. 329-334

Authors: VLAYKOVA T MUHONEN T HAHKAKEMPPINEN M PYRHONEN S JEKUNEN A

Citation: T. Vlaykova et al., VASCULARITY AND PROGNOSIS OF METASTATIC MELANOMA, International journal of cancer, 74(3), 1997, pp. 326-329

Authors: HAHKAKEMPPINEN M MUHONEN T KANGAS L PYRHONEN S

Citation: M. Hahkakemppinen et al., CHEMOSENSITIVITY OF HUMAN-MELANOMA METASTASES IN MOUSE SUBRENAL CAPSULE ASSAY - CAN IT PREDICT TUMOR RESPONSE TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY IN METASTATIC MELANOMA, Melanoma research, 6(3), 1996, pp. 215-221

Authors: HERNBERG M MUHONEN T TURUNEN JP HAHKAKEMPPINEN M PYRHONEN S

Citation: M. Hernberg et al., THE CD4+ CD8+ RATIO AS A PROGNOSTIC FACTOR IN PATIENTS WITH METASTATIC MELANOMA RECEIVING CHEMOIMMUNOTHERAPY/, Journal of clinical oncology, 14(5), 1996, pp. 1690-1696

Authors: HAHKAKEMPPINEN M MUHONEN T VIROLAINEN M JEKUNEN A ASKOSELJAVAARA S PYRHONEN S

Citation: M. Hahkakemppinen et al., RESPONSE OF SUBCUTANEOUS AND CUTANEOUS METASTASES OF MALIGNANT-MELANOMA TO COMBINED CYTOSTATIC PLUS INTERFERON THERAPY, British journal of dermatology, 132(6), 1995, pp. 973-977

Authors: MUHONEN T HAHKAKEMPPINEN M PAKKALA S PYRHONEN S

Citation: T. Muhonen et al., DECREASING CD4 CD8 RATIO DURING PROLONGED 4-DRUG CHEMOTHERAPY PLUS INTERFERON TREATMENT FOR METASTATIC MELANOMA/, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 67-73